ARDEA BIOSCIENCES, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 107
- Market Cap
- -
- Website
- http://www.ardeabio.com
Clinical Trials
68
Active:32
Completed:36
Trial Phases
4 Phases
Phase 1:29
Phase 2:7
Phase 3:7
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (44 trials with phase data)• Click on a phase to view related trials
Phase 1
29 (65.9%)Phase 2
7 (15.9%)Phase 3
7 (15.9%)Phase 4
1 (2.3%)Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.
Phase 1
Completed
- Conditions
- Gout
- Interventions
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03272425
- Locations
- 🇧🇷
CAEP - Centro Avançado de Estudos e Pesquisas Ltda., Campinas, Sao Paulo, Brazil
Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2016-09-02
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT02888054
RDEA3170 PK/PD Study
Phase 1
Completed
- Conditions
- Gout
- Interventions
- Drug: RDEA3170 4.5 mgDrug: RDEA3170 6 mgDrug: RDEA3170 12 mg
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2016-09-02
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02608710
Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: lesinurad/allopurinol 200/300 FDC tabletsDrug: lesinurad/allopurinol 200/200 FDC tablets
- First Posted Date
- 2015-10-21
- Last Posted Date
- 2016-12-19
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT02581553
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
- First Posted Date
- 2015-07-15
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Ardea Biosciences, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT02498652
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
No news found